Adequate control of primary EBV infection and subsequent reactivations after cardiac transplantation in an EBV seronegative patient

Transplant Immunology
Floor PietersmaD van Baarle

Abstract

EBV seronegative recipients of cardiac transplantation are at risk for development of post transplant lymphoproliferative disease following primary EBV infection due to the ongoing treatment with immunosuppressive drugs. Here we present detailed kinetics of the EBV-specific T-cell response following cardiac transplantation in an EBV seronegative recipient who developed a primary EBV infection 15weeks post transplantation and subsequent viral reactivations throughout follow up. The patient developed an EBV-specific CD8(+) T-cell response within 24days after first detection of the primary infection. Subsequently, an increased EBV-specific CD8(+) T-cell response developed upon viral reactivation, indicated by a threefold increase of EBV-specific CD8(+) T cells and increased IFNy production after stimulation with EBV-specific peptide pools. These data indicate that an EBV-specific T-cell response capable of adequate control of a primary EBV-infection and subsequent viral reactivations can develop in an EBV seronegative cardiac transplant recipient in the presence of severe immunosuppression.

References

May 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R C WalkerC V Paya
Jan 1, 1997·Annual Review of Immunology·A B Rickinson, D J Moss
Aug 17, 2000·The New England Journal of Medicine·J I Cohen
May 2, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Monique A MaloufAllan R Glanville
Feb 8, 2003·Journal of Clinical Microbiology·G J J van DoornumH G M Niesters
Jun 30, 2005·Transplant Infectious Disease : an Official Journal of the Transplantation Society·E MeijerL F Verdonck
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nicola E AnnelsArjan C Lankester
Jun 29, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dorothy H CrawfordAnthony J Swerdlow
Feb 4, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F L PietersmaD van Baarle

❮ Previous
Next ❯

Citations

Jan 27, 2019·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Lukas Marcelis, Thomas Tousseyn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.